In July 2023, the FTC released an investigation into OpenAI, the creator of ChatGPT, in excess of allegations that the business scraped general public information and published Wrong and defamatory details. The clinical trial supplied the contributors randomly picked to use Therabot with four weeks of unrestricted entry. The researchers https://elmarketeer.com/chat/